COVID-19 Antigen Detection Test - CLIA WAIVED (Coming Soon)

The Rapid Response™ COVID-19 Antigen Detection Test is a lateral flow immunochromatographic assay intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal swabs specimens from individuals with signs and symptoms of upper respiratory infection within the first six (6) days of symptom onset. The test is intended for use as an aid in the diagnosis of SARS-CoV-2 infections (COVID-19) in symptomatic individuals when either: tested at least twice over three days with at least 48 hours between tests; or when tested once, and negative by the Rapid Response™ COVID-19 Antigen Detection Test and followed with a molecular test. The test does not differentiate between SARS-CoV and SARS-CoV-2.